Umeå Biotech Incubator (UBI) has been awarded 2.5 million SEK in continued support from Kempestiftelserna for 2026. These funds are designated to assist verification activities for researchers and projects associated with UBI.
Nil Medical’s medical infusion vest, the “Nil Medical Vestpack,” is being tested at five hospitals in Sweden as part of a clinical trial. Now, the company is looking to hire a Business & Sales Manager.
“To achieve our goal of making the vest available to more children and hospitals, we need to grow our team,” says Martin Hanberger, CEO and founder of Nil Medical.
Just weeks after being granted a patent in Australia, Mucocort AB has achieved yet another significant milestone — this time in Japan. The newly approved patent for its innovative mucoadhesive patch, M045A, designed for the treatment of oral aphthous ulcers, further strengthens the company’s global presence.
QureTech Bio AB has been granted a patent by the European Patent Office (EPO) for GmPcides, a new class of synthetic antibacterials.
Umeå-based LIPUM AB has announced the successful completion of their Phase I study with SOL-116, reporting positive results.
Mucocort AB has successfully developed M045A, an innovative mucoadhesive “patch” for the treatment of oral aphthous ulcers. The company has now been granted a patent in Australia for its medical technology innovation, marking a significant milestone in its international expansion.
Lina Olsson, former CEO of HiloProbe, is stepping into a new role as Business Unit Manager at the consulting firm Prevas. The company is expanding into Umeå focusing on MedTech and Life Science.
On Tuesday, 25th Feb, researchers and industry representatives from Umeå’s Life Science sector will come together at Umeå University for Open Up For Innovation, an event designed to foster collaboration and drive innovation.
”A close dialogue between researchers and industry bridges scientific expertise with market needs, driving innovation—ultimately benefiting society through new treatments and solutions,” says Andreas Lindberg and Lisandro Bernardo from Umeå Biotech Incubator, who initiated the event.
Patient Safety Surveillance Solutions (P3S) is developing software that automatically monitors healthcare-associated injuries. Now, Tobias Tovedal, a business coach at Umeå Biotech Incubator (UBI), is stepping in as the new CEO of the Karolinska Institutet (KI) startup.
Dreaming of a career in life sciences? Loïc Talide decided to carve his own path.
A former postdoc at Umeå Plant Science Centre (UPSC), Loïc is now the founder of Labstuce, a company specializing in custom tools and solutions for life science researchers.
“No matter how far this journey takes me, the lessons I’ve learned are invaluable,” Loïc says.
Umeå Biotech Incubator (UBI) has once again been designated as an excellent incubator by the Swedish Innovation Agency, Vinnova and has been awarded SEK 14.6 million in excellence funding, ensuring financial support through 2029.
“This confirms that Vinnova has confidence in our work and our ability to help startups thrive,” says Peter Jacobsson, Acting Head of Operations of UBI.
Umeå has long been identified as a key actor within life science innovation and will soon be highlighted in an exciting new documentary project. Journalist and documentary filmmaker Luis Jachmann visited North Sweden to document Umeå’s role as a life science hub. This marked one holding point in the year-long documentary project, which aims to explore innovative initiatives across Europe and their connection to an integrated European continent.
Dr. Mikael Sellin has been appointed new Board member of QureTech Bio AB to represent the major investor, Kempestiftelserna.
Success didn’t come overnight, but ten years after its founding, Umeå-based HILICON has built a solid presence in 40 countries. The company is making its mark in the chromatography industry with consistent revenue growth and innovative products in the pipeline.
“My dream is to double the turnover in a few years,” says Wen Jiang, CEO and founder of HILICON.
MetaCurUm Biotech AB has been awarded one million SEK from the Swedish Innovation Agency, Vinnova, under the “Acceleration of Deeptech Companies 2024” initiative.
“This support is crucial for us as it brings us closer to securing additional funding that will help us advance to clinical trials,” says CEO Maarten de Château.
From December 2-13, Daniel Pacurar, an eco-tech innovator from northern Sweden, will join global leaders in Riyadh, Saudi Arabia, for UNCCD COP16, a climate conference focused on combating drought and desertification. Daniel has been invited to hold a seminar to present his innovative re:moss concept.
“With the help of the re:moss concept and technology, we aim to support the countries and regions facing these challenges,” says Daniel, Founder and Executive Chairman of Boreal Orchards.
Umeå-based Medicvent is seeking a new CEO as Erik Lindström transitions to a new role within the parent group, Sdiptech.
Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC).
“This approval is a significant step forward in our global growth strategy”, states Jean Lycke, Project Manager at Mucocort AB.
The city of Umeå is actively seeking life science companies interested in setting up operations in the region. Partnering with Umeå Biotech Incubator, the municipality sends a delegation to BIO-Europe – Europe’s largest life science conference – to forge new connections and promote Umeå’s strengths as a life science hub.
The European sunflower market is facing challenges and seeking new solutions. Cropcision, a Swedish startup, has the potential to contribute to this evolving landscape. Their plastic-free precision fertilizers will be tested in a sunflower trial, supported by EIT Food, in Spain in 2025.